As global markets navigate a complex landscape marked by interest rate adjustments and sector-specific shifts, the U.S. indices have shown resilience with notable performances in mid-cap and small-cap ...
Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolu ...
Dong-A ST (President/CEO Jae-Hun Jung, KRX:170900) announced on October 18 th that its biosimilar IMULDOSA ® (active ingredient: ustekinumab, development code DMB-3115), referencing Stelara ®, has ...